Status:
UNKNOWN
A Comparative Study on the Efficacy of AI Temperature-controlled Radiofrequency Technology and Electrical Stimulation in the Treatment of Vulvar Leukoplakia
Lead Sponsor:
Zhongnan Hospital
Conditions:
Vulvar Lichen Sclerosus
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
The study was designed as a prospective, multicenter, randomized, open-label, parallel-controlled clinical trial. The study population was patients with vulvar leukoplakia, and compared the efficacy a...
Eligibility Criteria
Inclusion
- Diagnosed by pathological examination, meeting the diagnostic criteria for leukoplakia;
- 18 to 60 years old;
- Agree to sign the informed consent;
Exclusion
- Patients with severe liver and kidney dysfunction;
- Combined with HIV, syphilis infection, acute vaginitis, cervical cancer;
- Patients with cardiovascular disease;
- People with hematological diseases;
- Patients with hypertension and diabetes;
- People with mental illness;
- Pregnant and lactating women.
Key Trial Info
Start Date :
July 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05250466
Start Date
July 7 2022
End Date
June 30 2024
Last Update
February 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China